discipline of pathology: selected publications.

Callagy GM, Webber MJ, Pharoah PD, Caldas C
Meta-analysis confirms BCL2 is an independent prognostic marker in breast cancer.
BMC Cancer. 2008 May 29;8:153.

Callagy GM, Pharoah PD, Pinder SE, Hsu FD, Nielsen TO, Ragaz J, Ellis IO, Huntsman D, Caldas C.
Bcl-2 is a prognostic marker in breast cancer independently of the Nottingham Prognostic Index.
Clin Cancer Res. 2006 Apr 15;12(8):2468-75. Erratum in: Clin Cancer Res. 2006 Aug
15;12(16):5002. 
 
Callagy G, Pharoah P, Chin SF, Sangan T, Daigo Y, Jackson L, Caldas C.
Identification and validation of prognostic markers in breast cancer with the complementary use of array-CGH and tissue microarrays.
J Pathol. 2005 Feb;205(3):388-96.

Callagy G, Jackson L, Caldas C.
Comparative genomic hybridization using DNA from laser capture microdissected tissue.
Methods Mol Biol. 2005;293:39-55. Review. 
 
Huang HE, Chin SF, Ginestier C, Bardou VJ, Adélaïde J, Iyer NG, Garcia MJ, Pole JC, Callagy GM, Hewitt SM, Gullick WJ, Jacquemier J, Caldas C, Chaffanet M,  Birnbaum D, Edwards PA.
A recurrent chromosome breakpoint in breast cancer at the NRG1/neuregulin1/heregulin gene.
Cancer Res. 2004 Oct 1;64(19):6840-4. 
 
Gonzalez MA, Tachibana KE, Chin SF, Callagy G, Madine MA, Vowler SL, Pinder SE, Laskey RA, Coleman N.
Geminin predicts adverse clinical outcome in breast cancer by reflecting cell-cycle progression.
J Pathol. 2004 Oct;204(2):121-30. 
  
 
Gonzalez MA, Pinder SE, Callagy G, Vowler SL, Morris LS, Bird K, Bell JA, Laskey RA, Coleman N.
Minichromosome maintenance protein 2 is a strong independent prognostic marker in
breast cancer.
J Clin Oncol. 2003 Dec 1;21(23):4306-13. 
 
Chin SF, Daigo Y, Huang HE, Iyer NG, Callagy G, Kranjac T, Gonzalez M, Sangan T, Earl H, Caldas C.
A simple and reliable pretreatment protocol facilitates fluorescent in situ hybridisation on tissue microarrays of paraffin wax embedded tumour samples.
Mol Pathol. 2003 Oct;56(5):275-9. 
 
Callagy G, Cattaneo E, Daigo Y, Happerfield L, Bobrow LG, Pharoah PD, Caldas C.
Molecular classification of breast carcinomas using tissue microarrays.
Diagn Mol Pathol. 2003 Mar;12(1):27-34. 
 
Callagy G, Dimitriadis E, Harmey J, Bouchier-Hayes D, Leader M, Kay E. 
Immunohistochemical measurement of tumor vascular endothelial growth factor in breast cancer. A more reliable predictor of tumor stage than microvessel density or serum vascular endothelial growth factor.
Appl Immunohistochem Mol Morphol. 2000 Jun;8(2):104-9.

• Disclaimer
• Privacy
• Copyright
• Accessibility